These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 19398483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 3. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
    Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S.
    Oncogene; 2004 Feb 05; 23(5):1052-63. PubMed ID: 14647449
    [Abstract] [Full Text] [Related]

  • 4. Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.
    Koduri S, Goldhar AS, Vonderhaar BK.
    Breast Cancer Res Treat; 2006 Jan 05; 95(1):37-43. PubMed ID: 16267616
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H, Dang CV.
    Cancer Res; 2000 Jan 01; 60(1):143-9. PubMed ID: 10646866
    [Abstract] [Full Text] [Related]

  • 7. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H, Li H, Chun P, Avraham S, Avraham HK.
    Oncogene; 2002 Oct 31; 21(50):7730-9. PubMed ID: 12400015
    [Abstract] [Full Text] [Related]

  • 8. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
    Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot-Applanat M.
    J Endocrinol; 2008 Feb 31; 196(2):399-412. PubMed ID: 18252963
    [Abstract] [Full Text] [Related]

  • 9. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I.
    Mol Cancer; 2006 Nov 05; 5():57. PubMed ID: 17083744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
    Hervé MA, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S, Perrot-Applanat M.
    J Endocrinol; 2006 Jan 05; 188(1):91-9. PubMed ID: 16394178
    [Abstract] [Full Text] [Related]

  • 12. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B, Zhang Y, Luo G, Li L, Zhang J.
    Anat Rec (Hoboken); 2009 May 05; 292(5):633-9. PubMed ID: 19382240
    [Abstract] [Full Text] [Related]

  • 13. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
    Ge YL, Zhang X, Zhang JY, Hou L, Tian RH.
    Int Immunopharmacol; 2009 Apr 05; 9(4):389-95. PubMed ID: 19162240
    [Abstract] [Full Text] [Related]

  • 14. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 15. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D.
    Clin Cancer Res; 2003 Sep 15; 9(11):4221-6. PubMed ID: 14519649
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.
    Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW.
    Cancer Res; 2003 Feb 15; 63(4):812-6. PubMed ID: 12591731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
    Kadenhe-Chiweshe A, Papa J, McCrudden KW, Frischer J, Bae JO, Huang J, Fisher J, Lefkowitch JH, Feirt N, Rudge J, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ.
    Mol Cancer Res; 2008 Jan 15; 6(1):1-9. PubMed ID: 18234958
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.